Press Alt+1 for screen-reader mode, Alt+0 to cancelAccessibility Screen-Reader Guide, Feedback, and Issue Reporting | New window
Get 20% Off Your First Purchase — Use Code FIRST20 at Checkout

Regulatory Due Diligence for FDA Regulated Companies

Presented byDarshan Kulkarni
Rating4.65,616 ratings
Length59min
CLE Accreditation
Accredited in 22 states

Sign up for a free account anytime during this 5 minute preview and resume your course right where you left off.

Video Player is loading.
1 / 1
Current Time 0:00
Loaded: 0%
Duration -:-
  • Transcript_1095Download
  • Course Outline and Description - Regulatory Due Diligence for FDA Regulated CompaniesDownload
  • Regulatory Due Diligence for FDA Regulated Companies - SlidesDownload

Watch this course on the go or download for offline viewing with the LexVid mobile app. Get the app.

What You'll Learn

  • Master the current legal and regulatory framework affecting life sciences acquisitions due diligence
  • Build essential skills for spotting and evaluating risks in life science companies

About This Course

Length: 59minPublished: 4/9/2024Closed captions: Yes
Join this Continuing Legal Education (CLE) session to get the latest insights and updates on how to effectively conduct due diligence for acquisitions in the life sciences sector, considering the dynamic legal, regulatory, and compliance environment. Key Topics: - DOJ, OIG, and ORI investigations impact: Discover how recent actions and advisories from the Department of Justice (DOJ), Office of Inspector General (OIG), and Office of Research Integrity (ORI) influence due diligence efforts. We'll cover crucial aspects such as adherence to the False Claims Act, the integrity of clinical trial data, and handling of research misconduct. - Updates on FDA regulations: Dive into the most recent changes and enforcement actions by the Food and Drug Administration (FDA) and understand how they alter the risk landscape for potential acquisitions. -New legal and regulatory developments: Unpack the latest trends in the life sciences sector, including CRAACO, decentralized studies, and others, and how to evaluate the compliance risks they present.

Presented By

Photo of Darshan Kulkarni

Darshan Kulkarni

FDA Regulatory Attorney | Life Sciences | Former Pharmacist

Rydal, PA

  • 4.6Average Rating
  • 3Courses Taught
  • 11,761Attorneys Taught

Darshan Kulkarni has more than two decades of experience helping companies regulated by the Food and Drug Administration to develop, protect and distribute their products and innovations. Having been a pharmacist for more than 10 years, he has substantive technical experience that makes him uniquely equipped to assist clients across all stages of the product development process, including regulatory strategy, clinical trial, genericization, manufacturing and FDA reviews and compliance benchmarks. Additionally, Darshan advises on advertising requirements for FDA regulated products including drugs, cosmetics, foods and medical devices.

Darshan's Practice Areas

FDA RegulatoryLife Sciences & BiotechnologyClinical TrialsPromotional ComplianceMedical AffairsHealth CareAdministrative Law
View Profile and All Courses

Recommended Courses

See all courses